BlackRock Group’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
2015
Q1
$929K Buy
2014
Q4
$402K Buy
2014
Q3
$281K Sell
2014
Q2
$435K Sell
2014
Q1
$727K Sell
2013
Q4
$2.52M Buy
2013
Q3
$2.29M Sell
2013
Q2
$2.62M Buy